Dual Modal Imaging-Guided Drug Delivery System for Combined Chemo-Photothermal Melanoma Therapy
Dong Zhang1,2,3, Weifen Zhang1,2, Xinghan Wu1
1Shandong Engineering Research Center for Smart Materials and Regenerative Medicine, Weifang, 261053, People's Republic of China.
Purpose:
Malignant melanoma is one of the most devastating types of cancer with rapid relapse and low survival rate. Novel strategies for melanoma treatment are currently needed to enhance therapeutic efficiency for this disease. In this study, we fabricated a multifunctional drug delivery system that incorporates dacarbazine (DTIC) and indocyanine green (ICG) into manganese-doped mesoporous silica nanoparticles (MSN(Mn)) coupled with magnetic resonance imaging (MRI) and photothermal imaging (PI), for achieving the superior antitumor effect of combined chemo-photothermal therapy.
Materials And Methods:
MSN(Mn) were characterized in terms of size and structural properties, and drug loading and release efficiency MSN(Mn)-ICG/DTIC were analyzed by UV spectra. Photothermal imaging effect and MR imaging effect of MSN(Mn)-ICG/DTIC were detected by thermal imaging system and 3.0 T MRI scanner, respectively. Then, the combined chemo-phototherapy was verified in vitro and in vivo by morphological evaluation, ultrasonic and pathological evaluation.
Results:
The as-synthesized MSN(Mn) were characterized as mesoporous spherical nanoparticles with 125.57±5.96 nm. MSN(Mn)-ICG/DTIC have the function of drug loading-release which loading ratio of ICG and DTIC could reach to 34.25±2.20% and 50.00±3.24%, and 32.68±2.10% of DTIC was released, respectively. Manganese doping content could reach up to 65.09±2.55 wt%, providing excellent imaging capability in vivo which the corresponding relaxation efficiency was 14.33 mM-1s-1. And outstanding photothermal heating ability and stability highlighted the potential biomedical applicability of MSN(Mn)-ICG/DTIC to kill cancer cells. Experiments by A375 melanoma cells and tumor-bearing mice demonstrated that the compound MSN(Mn)-ICG/DTIC have excellent biocompatibility and our combined therapy platform delivered a superior antitumor effect compared to standalone treatment in vivo and in vitro.
Conclusion:
Our findings demonstrate that composite MSN(Mn)-ICG/DTIC could serve as a multifunctional platform to achieve a highly effective chemo-photothermal combined therapy for melanoma treatment.
Insights
This study developed a multifunctional drug delivery system using manganese-doped mesoporous silica nanoparticles (MSN(Mn)) loaded with dacarbazine (DTIC) and indocyanine green (ICG). This system demonstrated superior antitumor effects for melanoma through combined chemo-photothermal therapy.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Malignant melanoma presents a significant challenge due to rapid relapse and low survival rates.
- Novel therapeutic strategies are crucial for enhancing melanoma treatment efficacy.
- Current treatments often lack targeted delivery and combined therapeutic approaches.
Purpose of the Study:
- To fabricate a multifunctional drug delivery system for melanoma treatment.
- To incorporate dacarbazine (DTIC) and indocyanine green (ICG) into manganese-doped mesoporous silica nanoparticles (MSN(Mn)).
- To achieve a superior antitumor effect via combined chemo-photothermal therapy using MRI and photothermal imaging.
Main Methods:
- MSN(Mn) nanoparticles were synthesized and characterized for size and structure.
- Drug loading and release efficiency of MSN(Mn)-ICG/DTIC were analyzed.
- In vitro and in vivo studies using A375 melanoma cells and tumor-bearing mice were conducted to evaluate therapeutic efficacy and imaging capabilities.
Main Results:
- MSN(Mn)-ICG/DTIC nanoparticles exhibited excellent drug loading (ICG: 34.25±2.20%, DTIC: 50.00±3.24%) and release profiles.
- Manganese doping (up to 65.09±2.55 wt%) provided effective MRI contrast and photothermal heating capabilities.
- The combined therapy demonstrated superior antitumor effects and excellent biocompatibility in vitro and in vivo compared to standalone treatments.
Conclusions:
- Composite MSN(Mn)-ICG/DTIC nanoparticles represent a promising multifunctional platform for melanoma treatment.
- The developed system enables effective chemo-photothermal combined therapy.
- This approach offers a potential strategy for improving therapeutic outcomes in melanoma patients.
More Related Videos
09:01Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017